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Background/aim: To assess the efficacy of postoperative antibiotics on postoperative infection in clean supratentorial craniotomies.
Material and methods: This study is a prospective, randomized, single-blind, and placebo-controlled clinical trial that included
consecutive patients who underwent clean supratentorial craniotomy between November 2017 and September 2020 and evaluated the
effectiveness of postoperative antibiotic prophylaxis on postoperative infection.
Results: A total of 80 patients were included and the whole group was divided into two groups. Group A included patients who received
antibiotic prophylaxis and group B who did not receive antibiotic prophylaxis after surgery. Each group included the same number of
patients (40 patients in each). Two patients showed postoperative infection, and both were in group B. No significant difference was
found regarding postoperative infection between the two groups (p = 0.15). The rate of postoperative infection was found to be 2.5% in
the whole group (2 cases out of 80) and it was 5% in group B (2 cases out of 40).
Conclusions: Our results showed that antibiotic prophylaxis after a clean supratentorial craniotomy has no effect on the prevention of
postoperative infection and we do not suggest using antibiotic prophylaxis after clean supratentorial neurosurgery.
Key words: Antibiotic prophylaxis, clean neurosurgery, postoperative infections

1. Introduction
Postoperative infections (PI) are one of the most important
and challenging clinical problems for neurosurgeons
because when it is inappropriately managed, it can lead to
high morbidity and mortality rates. The reported incidence
of PI rates in neurosurgery are 0.8% and 8%, respectively
[1–5]. The rate in clean craniotomy is even lower, account
for almost 1% and gram-positive Staphylococci have been
reported to be the most common causative pathogens
[3]. Apart from threatening life of patients, PI lead also
to longer hospital stay and increase cost. In neurosurgery,
PI generally include wound and bone flap infections
(osteomyelitis), meningitis, encephalitis and abscess.
Neurosurgeons always keep themselves alert when they
make daily visits after surgery related to wound infection
because if not managed properly, it can lead to serious
complications such as meningitis, abscess and even death.
After Malis et al. [6] reported no infection in a high
number of major clean neurosurgery with antibiotic

prophylaxis (AP) in 1979, a series of randomizedcontrolled trials (RCTs) [7–11] appeared in the
literature that supported the use of AP in neurosurgery.
Furthermore, some meta-analysis [7,12] and retrospective
studies [13] concluded that AP was effective in preventing
PIs. However, widespread use of AP resulted in drug
abuse, drug-resistance, changes in bacterial spectrum
and high cost. As time passes, use of AP was started to
be questioned after some clinical studies were reported
[13,14]. Some underlined that although AP was effective
in decreasing surgical site infections (SSI) [2], it had no
effect on meningitis [8,9,15] and some clinical studies
reported that AP is not valid in clean neurosurgery [16].
Thus, there is no common consensus on the use of AP
in clean neurosurgery and the debate still exists in this
modern era.
In addition of these discussions, there is no common
consensus on antibiotics administration after surgery
and prospective studies in literature are inadequate. It
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is reported in the U.S. Food and Drug Administration
(FDA) database on cefazolin antibiotics that cefazolin
can be continued for 3 to 5 days in the post-op period1.
The aim of this prospective, randomized, single-blind,
placebo-controlled study is to provide data on whether
clean supratentorial craniotomies need postoperative
antibiotics.
2. Material And methods
2.1. Study design
This prospective and randomized clinical trial included
patients who underwent elective supratentorial clean
craniotomy due to supratentorial pathology including
tumor and epilepsy between November 2019 and February
2021 in the Department of Neurosurgery, Cerrahpaşa
Medical Faculty, İstanbul University-Cerrahpaşa, İstanbul,
Turkey. Detailed informed consent was signed by all
patients before surgery. All patients received prophylactic
antibiotics during the surgery. In the postoperative period
half of the patients were received antibiotics, the other half
did not. Randomization for postoperative antibiotics were
achieved with a computerized random list. Medical staff
was aware of the postoperative treatment, but patients
were not. All patients were operated by the same surgeon
with the same surgical preparation and surgical technique.
The study was approved by local Ethics Committee of
our hospital. We have to state that at the beginning of the
study, we planned to include as many patients as possible;
however, we had to terminate the study early because of
COVID-19 pandemic.
2.2. Treatment protocol
Every patient received 2 g of cefazolin, a first-generation
cephalosporin, just following induction of anesthesia.
Depending on duration of surgery, appropriate dose of
antibiotic was given at every 4-h interval. Ciprofloxacin,
a fluoroquinolone antibiotic, was planned for patients
who had cephalosporin allergy. According to length of
hospital stay, the patients in the postoperative antibiotic
group (Group A) received the same antibiotic as U.S. FDA
had approved as the daily therapeutic dose2 (three times a
day; daily dose of 3 g of cefazolin) and other patients in the
nonantibiotic group (Group B) received a placebo (0.9%
saline in water) of identical appearance until discharge.
2.3. Patients
In order to provide homogeneous results and decrease
the study bias, some selection criteria were applied. Only
adult patients (≥18 years of age) who underwent elective
supratentorial clean craniotomy were included. Any

patient who had any sign of infection during preoperative
measures including laboratory and radiology studies
was excluded. Two patients in whom the frontal sinus
were opened inadvertently during craniotomy and six
patie nts who needed a device for cerebrospinal fluid
drainage after surgery were excluded. One patient who
underwent immediate reoperation for postoperative
surgical complication was excluded. Any patient who
was on chemotherapy and on long-term steroid therapy
for any reason was also excluded. Finally, 80 patients for
this prospective clinical study met the criteria and were
included.
The collected data for each patient included age;
sex; presenting symptom(s); neurological examination
and radiological findings; laboratory measurements
including C-reactive protein, leukocyte, lymphocyte,
thrombocyte and neutrophil counts; dates of hospital
admission and surgery; duration of anesthesiology
and surgery; postoperative neurological examination
findings; measurement of vital signs during hospital stay;
duration of intensive care unit stay following craniotomy;
placement and duration of subgaleal drains; pathological
diagnosis; cost of antibiotic used and presence of PI and
their management.
The same surgical preparation was applied to all
patients in the operating room by the same surgical team.
Immediately after induction of anesthesia and prior to
surgery, surgical site was electrically clipped and dryshaved with disposable razor blades. The head then was
fixed with three-pinned head holder for final craniotomy
position. Craniotomy field was then prepared with a
polyvidone-iodine solution. Adhesive drapes were never
used.
The follow-up procedures with the same surgeon and
residents after surgery or during hospital stay consisted
of 1) patient’s visit was performed every day; 2) clinical
and/or neurological status was evaluated; 2) wound
inspection was done every day; 3) vital sings including
body temperature was measured every day; 4) hemogram
parameters and electrolytes were obtained every other day;
and 5) every patient was followed-up at 3-months interval
after discharge. In this study, after hospital discharge,
hemogram parameters and electrolyte measures including
C-reactive protein were obtained at the time of suture
removal (10th day of surgery).
Postoperative central nervous system infections
such as meningitis and cerebral abscess and SSIs were
diagnosed according to the guidelines of the Centers for
Disease Control [17].

U.S. Food and Drug Administration (2011). Cefazolin for Injection, USP. [online]. Website https://www.accessdata.fda.gov/drugsatfda_docs/
label/2013/065247s011lbl.pdf [accessed 15 March 2022]
1

U.S. Food and Drug Administration (2011). Cefazolin for Injection, USP. [online]. Website https://www.accessdata.fda.gov/drugsatfda_docs/
label/2013/065247s011lbl.pdf [accessed 15 March 2022]
2
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3. Statistical analysis
In this study SPSS software (version 20.0, IBM, USA) was
used for statistical analysis. The “Student’s t-test” was used
to compare continuous variables. In analysis of categorical
variables “chi-square test” was used. A p-value less than
0.05 was considered statistically significant.
4. Results
4.1. General information
The whole group consisted of 80 patients with a mean age
of 40.75 ± 15.7 (ranging from 18 to 75 years old) years.
In the group there were 39 males (48.8%) and 41 females
(51.2%). The majority of patients (n = 34; 42.5%) had
seizure as presenting symptom, followed by headache (n =
23; 28.7%) and numbness on one side of the body (n = 8;
10%). The rest showed several other symptoms including
paresis, decrease level of consciousness, and dysphasia. In
8 patients, there were no presenting symptoms and the
pathology was incidentally found on cranial magnetic
resonance imaging (MRI). MRI showed the pathology
on the right side in 42 (52.5%) and left side in 38 (47.5%)
patients. Mean duration of anesthesia (from the induction
to wake-up of the patients) was 154.12 ± 45.4 min (ranged
from 60 to 280 min) and mean duration of surgery (from
the skin incision to the last suture of the skin) was 107.15 ±
40.4 min (ranged from 25 to 220 min). A total of 18 patients
(22.5%) required one-night stay in the intensive care unit
(ICU) after surgery. In the whole group, histopathological
diagnoses were as follows: astrocytoma in 25 (31.2%),
meningioma in 19 (23.7%), temporal lobe epilepsy
(hippocampal sclerosis) in 13 (16.2%), neuroepithelial
tumor in 8 (10%), extra-temporal epilepsy in 7 (8.8%),

metastasis in 5 (6.3%), and cavernoma in 3 (3.8%) patients.
Mean hospital stay was 4.65 ± 2.7 days and PI was seen in
only 2 (2.5%) patients. After discharged from the hospital,
all patients were scheduled to be followed-up at 3-month
interval in our out-patient clinic.
4.2. Group comparisons
Following completion of the trial, the data was evaluated
and patients were divided into those who received
antibiotics after surgery (group A: 40 patients) and those
who did not receive antibiotics after surgery (group
B: 40 patients) during hospital stay. Table 1 and Table 2
summarize some variables related to preoperative and
postoperative periods, respectively. None of the variables
including mean age, gender, lateralization of the pathology,
preoperative C-reactive protein, and preoperative
hemogram parameters including leukocyte, lymphocyte,
thrombocyte and neutrophil counts showed significant
difference between the groups (p > 0.05). As shown in
Figure the highest mean values in C- reactive protein
(CRP) were reached on second and third postoperative
days. Mean duration of anesthesia and surgery also did
not show significant differences between the groups (p >
0.05). Postoperative hemogram parameters and C-reactive
protein were evaluated at the time of suture removal
(almost 10th day of postsurgery). None of the parameter
showed significant difference between the groups although
C-reactive protein and lymphocyte count were slightly
higher in group B compared to group A. Following surgery,
5 patients (12.5 %) in group A and 13 patients (32.5 %) in
group B required one-night ICU stay. On postoperative
day 1, 6 patients (15 %) in group A and 10 patients (25
%) in group B; on postoperative day 2, 3 patients (7.5 %)

Figure. Boxplot graph of preoperative and
postoperative CRP values.
The highest mean values in CRP were reached on
the second and third postoperative days. It started to
decrease after the third day and reached the lowest mean
value postoperative 10th day. CRP: C-Reactive Protein
(mg/dL). Preop: Preoperative. PO: Postoperative.

1650

KORKMAZ et al. / Turk J Med Sci
Table 1. Demographic and preoperative clinical and laboratory variables in both groups.
Variables

Group A (n = 40)

Group B (n = 40)

p-values

Mean age (years)

39.4 ± 15.2

42.0 ± 16.3

0.4

Gender (male/female)

22/18

17/23

0.2

Lateralization (right/left)

21/19

21/19

1

C-reactive protein (mg/dL)

2.23 ± 1.89

4.42 ± 11.1

0.2

Leukocyte count (103 mm3)

8.79 ± 4.2

8.30 ± 3.6

0.5

Lymphocyte (10 mm )

2.04 ± 0.6

2.06 ± 0.6

0.8

Thrombocyte (103 mm3)

265.5 ± 81.2

267.2 ± 78.4

0.9

Neutrophil (10 mm )

5.96 ± 4.1

5.49 ± 3.1

0.5

3

3

3

3

Group A: Patients who received postoperative antibiotic prophylaxis during hospital stay. Group B: Patients who did not
receive postoperative antibiotic prophylaxis during hospital stay. None of the p-values are less than 0.05.

Table 2. Surgical and postoperative clinical and laboratory variables in both groups.
Variables

Group A (n = 40)

Group B (n = 40)

p-values

Mean anesthesia duration (min)

156.2 ± 51.9

152.0 ± 38.2

0.6

Mean surgery duration (min)

107.5 ± 46.0

106.7 ± 34.4

0.9

*C-reactive protein (mg/dL)

10.5 ± 8.2

11.2 ± 21.9

0.8

*Leukocyte count (103 mm3)

10.57 ± 4.9

9.8 ± 3.5

0.4

*Lymphocyte (10 mm )

2.26 ± 0.6

2.42 ± 1.1

0.4

*Thrombocyte (103 mm3)

329.1 ± 89.8

324.9 ± 75.2

0.8

*Neutrophil (10 mm )

7.44 ± 4.5

6.69 ± 3.0

0.3

3

3

3

3

Mean hospital stay (day)

5.25 ± 2.3

6.05 ± 3.0

0.1

Postop. infection(s)

0

2

0.15

Group A: Patients who received postoperative antibiotic prophylaxis during hospital stay. Group B: Patients who did not
receive postoperative antibiotic prophylaxis during hospital stay. None of the p-values are less than 0.05. Postop: Postoperative.
*Hemogram parameters at the 10th day of surgery (time of suture removal).

in each group, and on postoperative day 3, only 1 patient
(2.5 %) in group B had fever (≥38 °C). No significant
differences were found (p > 0.05). Following days, no fever
was found in both groups. Mean hospital stay was slightly
higher in group B compared to group A but the difference
did not reach a significant level (p > 0.05).
4.3. Postoperative infection
In this study PI was seen in only 2 patients (2.5% in the
whole group) and these two patients were in group B (5
% in group B). Statistical analysis did not show significant
difference regarding postoperative infection between the
two groups (p = 0.15). Two patients who had postoperative
infection merit further discussion. The first patient was
43-year-old male and operated on right temporal tumor.
The histopathological diagnosis was grade-IV astrocytoma

and postoperative period he had Wernicke dysphasia. The
patient was discharged from the hospital on postoperative
day 6. One day after discharge, the patient admitted to
our clinic with drainage of serous-purulent fluid from
incision, seizure and fever. The body temperature was
38.7 °C and radiological examination showed nothing
abnormal. Infectious disease consultation was asked,
drainage, urine and blood cultures were performed. The
patient was evaluated as superficial incisional SSI, broad
spectrum antibiotics were started. During hospital stay,
vital signs were normal and the results of cultures were
negative. Daily care was performed at the incision site.
The patient was completed antibiotic therapy for 10 days
and discharged without any sequela. The second was
23-year-old male and operated on the right parietal tumor.
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The histopathologic diagnosis was grade-III astrocytoma
and the postoperative period was uneventful. The patient
was discharged from the hospital on postoperative day 4.
Eleven days after discharge, the patient was admitted to
our clinic with drainage of serous fluid from the incision.
The radiological examination showed no abscess or any
sing of intracranial infection. Neurological examination
showed no signs of meningitis. The patient was taken to
the operating room where skin was opened and the bone
flap was elevated to inspect the dura for any fistula. There
was no leakage from the dura and samples from the wound
material and serous fluid were taken for culture. Then the
bone flap was placed and the skin was closed primarily.
Infectious disease consultation was asked and depending
on their advice, samples of blood and urine were also
taken for culture. The patient was evaluated as superficial
incisional SSI. The patient was put on 10-day antibiotic
treatment. Postoperative period was uneventful and no
abnormal vital signs including body temperature were
found. All the cultures were negative and after completion
of antibiotic treatment, the patient was discharge from the
hospital without any sequela.
4.4. Cost analysis
In this study, each patient was received 2 g cefazolin during
the surgery and the total cost of these antibiotics was 1500
Turkish Liras (TL) (ranged from 13 to 27 TL; by dollar rate
almost 1.6 to 3.5 United States Dollars (USD)).
A total of 40 patients (group A) were given
postoperative AP during hospital stay. The mean dose of
antibiotic given was 8.92 ± 3.02 gm and the mean cost was
83,000 TL (ranging from 32.65 to 238 TL; by dollar rate
almost 4 to 30 USD).
The two patients who had PI were followed in the ward
for 10 days, one of them was reoperated because of wound
dehiscence. When all costs are calculated, including
the ward follow-ups of two patients, the antibiotics
administered and the cost of surgery performed one
patient, the total approximately 9600 TL.
We have to underline that the health-care costs in our
country changes depending on changes of USD against
TL. During preparation of this manuscript 1 USD equaled
to 7.86 TL. Thus, in this study the costs of cefazolin
antibiotics used and treatment of PI were almost 12,000
USD (94,000 TL = 12,000 USD).
5. Discussion
It is clear that proper diagnosis and timely management
of PI is utmost importance not only after neurological
surgery but also after surgical interventions in other
specialties. As a neurosurgeon, we know that even after
clean craniotomy, improper management of PI such as
simple wound infection, may lead to serious complications
such as meningitis, cerebral abscess and even death. That
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is why neurosurgeons should keep themselves alert after
surgery during follow-up periods. Neurosurgeons have
adopted to use AP in neurosurgery in order to decrease
the number and severity of PIs. However, it should be kept
in mind that AP does not entirely prevent PIs.
Widespread use of AP in neurosurgery has begun after
a series of RCTs [7–11] and some meta-analysis [12,18]
were reported in 1980s and 1990s. The majority of early
studies reported that AP significantly decreases rate of PIs,
especially meningitis and SSIs. In the current literature,
there are serious critics related to early reports that they
had limitations. Furthermore, it should be noted that
there was no advanced surgical equipment; surgical and
anesthesiological managements were not as advanced as
today and also there were logistic problem that wards were
not close to ICU and more than one patient in a single
room.
As time passes, substantial progress has been made
in disinfection processes, ICU and ward conditions,
and surgical techniques and equipment. All these
advancements made surgery safe and helped surgeons to
diagnose and have proper management of PIs. Thus, recent
retrospective studies [13–16] failed to show effectiveness
of AP in PIs, especially meningitis and wound infections
after clean craniotomies. These controversies in recent
years led to questioning about the use of AP, especially
after clean neurosurgery. They pointed out that in the early
years, Cushing was able to keep wound infection rate less
than 1% by using only soap and water [19]. Misuse of AP
increases drug-resistance, changes bacterial spectrum and
increases cost. It has also been reported that meningitis
is not occurred during surgery, rather it is occurred after
surgery due to cerebrospinal fluid leak and they underlined
that AP has no effect on prevention of meningitis
[2,7,15]. A recent retrospective data including high
number of patients (808 patients) who underwent clean
neurosurgery showed that AP had no preventive effect on
PI and furthermore, AP decreased culture-positivity and
increased multi-rug resistant bacteria. They concluded
that careful surgical technique and postoperative care
are more effective than AP itself on PIs [16]. In order
to eliminate the debate whether AP is required in clean
craniotomies, more RCTs are needed but recent studies
related to AP in neurosurgery generally are retrospective
series of patients or meta-analysis because we think that
it is ethically difficult today to perform RCTs compared
to the periods of 1980s and 1990s. Even among early
trials, opposite or contradictory results were also present
[20]. However, the common consensus from the studies
reported so far is that, if necessary, AP should be given
timely to reduce the microbial burden of intraoperative
contamination level that cannot overwhelm the host’s
defense.

KORKMAZ et al. / Turk J Med Sci
In the literature, there are not enough RCTs regarding
to postoperative antibiotics, which is an important issue. In
our prospective RCT, we evaluated whether postoperative
use of antibiotics during hospital stay is required in
supratentorial clean craniotomies. Our findings related to
PI are in line with almost all of the previously published
studies which reported PI rate that ranged from 1% to
11% [5,18] and even lower in clean neurosurgery. Our
postoperative infection rate was found to be 2.5% in the
whole group (n = 80 patients) and 5% in no-AP group (n
= 40). We did not find significant difference related to the
occurrence of PI between those who had and had not AP
during hospital stay. A total of 2 patients had PI and both
were in no-postoperative antibiotics group. All bacterial
cultures that we performed were negative but both
patients evaluated superficial SSI and received antibiotics.
C-reactive protein and lymphocyte counts were slightly
higher in no-AP group compared to AP-group but the
difference was not significant. This difference was evaluated
as the patients who had postoperative infection were in
no-AP group. For all the groups, the highest mean values
in CRP were reached on second and third postoperative
days. After these days, it started to decrease after the third
day and reached the lowest mean value postoperative
10th day. Depending on our results we propose that
postoperative use of antibiotics is not required and should
not be given after clean supratentorial craniotomies. We
agree with some previously published reports that careful
surgical techniques and postoperative care are more
effective than postoperative antibiotics on PIs [16,20].
Duration of surgery should be kept short as much as
possible by decreasing unnecessary manipulations. We
are aware of that it is very difficult to discuss and compare
our results with the previously published studies with
respect to PIs. The main difficulty is due mainly to the
differences among the study protocols and situation of
the hospital and or department or clinic where you are
performing neurosurgery. Some previous studies included
supratentorial and infratentorial interventions [21], some
had craniotomies including burr-holes and ventriculoperitoneal shunts (VPS) [9], and some had spinal and
cranial surgeries [22] and furthermore some studies
included emergency patients [2,20]. Aforementioned
situations clearly change infection rate such as insertion of
VPS or ventricular drainage especially after infratentorial
interventions that may increase the infection rate and all
these interventions make comparisons challenging. In this
study we included patients who underwent supratentorial
clean craniotomies only and were careful to select patients
with almost similar demographic characteristics.
We are sure that almost every neurosurgeon knows that
inappropriate use of antibiotics with prolonged duration
can cause drug resistance, changes bacterial spectrum

and leads to high cost. Thus, the question that should be
asked: Why majority of neurosurgeons in developing or
even in developed countries, are still using postoperative
antibiotics after clean neurosurgery? We think that there
are three answers to this question: 1) surgeon’s habit
or preferences; 2) lack of national guidelines regarding
control of use of AP; and 3) low level or lack of adherence
to the available national guidelines.
Inappropriate use of antibiotics is a global problem
irrespective of development status of the states. High
rate of inappropriate use of AP has already been reported
from our country, Turkey [23,24]. Furthermore, a
cross-national database study reported by World
Health Organization (WHO) in 2014 showed that use
of antibiotic is highest in Turkey among European
countries [25]. We have to underline that prolonged
use of AP after surgery is a common practice in
neurosurgical departments or clinics including ours in
Turkey although almost every neurosurgeon knows that
PI rate is low in clean neurosurgery. Although there are
well-established guidelines related to AP throughout the
world, inadequacy of adherence is a big issue worldwide.
A report from Iran showed that the rate of inadequate
compliance to guidelines for timing of antibiotics use
is 74.3% and duration of use is almost 5 days [26].
Poor adherence was also reported from other countries
including Singapore [27] and Jordan [28] with respect
to timing, selection, dose and duration of postoperative
antibiotics use. A recent report from one of the
developed countries, Australia, pointed out that 40.3%
of postoperative antibiotic prescriptions was classified
as inappropriate and 45.2% as noncompliant with
Australian National Therapeutic Guidelines [29]. Even in
Germany [30], USA [14], UK [31], and Japan [32], half
or more than half of prescriptions of antibiotics were not
in full compliance with the guidelines and the doctors
failed to prescribe antibiotics which were associated with
inappropriate timing, selection, and prolonged duration.
In Turkey, there is no common consensus on AP use and
no strict national guidelines that can control antibiotic
use. In almost all neurosurgical facilities AP is being
used and the duration is longer on postoperative days.
Infectious disease specialists are the main authority that
control antibiotic use in surgical specialties including our
own department. Thus, surgeons feel free to prescribe
antibiotics and they decide the duration of antibiotics
after surgery because of lack of restrictions. Furthermore,
studies from Turkey revealed that the majority of surgeons
do not carry out use of AP guidelines [23,24]. The most
common practice or habit among surgeons is prolonged
use of postoperative antibiotics which is generally more
than 5 days. Especially in private hospitals in Turkey,
patients after clean craniotomies are discharged from
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hospital with oral antibiotics until the time of suture
removal (personnel communication with colleagues
worked in private hospitals).
Apart from medical consequences of inappropriate use
of AP, increased cost should be taken into consideration.
Cost effectiveness is vital for every country, especially
for underdeveloped and developing countries because
of limited sources. In accordance with the main purpose
of this study, we would like to draw attention to the cost
of antibiotics used unnecessarily after surgery. In our
study, 40 patients used AP in the postoperative days until
discharge from our hospital and the cost was 83,000 TL
which almost equals to 10,600 USD. This amount may
not be considered as a high price for a developed country,
but it matters in under-developed and/or developing
countries, like our country, Turkey, when we think about
the minimum salary of a worker in Turkey in 2020 is
2324 TL which equals to almost 303 USD per month. In
short, we have to think about socio-economic burden of
inappropriate use of AP in the countries, such as in Turkey
where the National Insurance of Health is covering more
than 90% of the population throughout the country.
6. Limitations
The authors of this prospective study are aware of the
limitations. We think that the single most important
limitation of this study is the number of the patients. At
the beginning of the study, we planned to include more
patients but unfortunately, we had to terminate the study
early due mainly to COVID-19 pandemics. Future studies
should be prospective and should include a greater number
of neurosurgical patients (ideally should be national or
international multi-centric) in order to provide more

reliable data related to use of postoperative antibiotics in
clean neurosurgery.
7. Conclusion
Our data showed that postoperative antibiotics have no
effect on PI after clean supratentorial craniotomies and no
difference was found between the groups with and without
postoperative antibiotic. Careful handling of surgery
and postoperative care seem to be more important and
effective than postoperative antibiotics.
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